Functional assays revealed that CTSS suppression enhanced T-cell activation and cytotoxicity against CRC cells, implicating CTSS as a key contributor to the immunosuppressive TME and a potential immunotherapeutic target in CRC. This evidence concerns the gene CTSS and colorectal carcinoma.